Radiotherapy-related lung fibrosis enhanced by tamoxifen

Journal of the National Cancer Institute

Volumn 88, Issue 13, 1996, Pages 918-922

  Bentzen, Søren M ^a   Skoczylas, Jerzy Z ^a   Overgaard, Marie ^b   Overgaard, Jens ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MASTECTOMY; ORAL DRUG ADMINISTRATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; PULMONARY FIBROSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029987480     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.13.918     Document Type: Article

References (32)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group [see comment citations in Medline]. Lancet 1992;339:1-15.
2. Colletta AA, Wakefield LM, Howell FV, van Roozendaal KE, Danielpour D, Ebbs SR, et al. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 1990;62:405-9.
3. Butta A, MacLennan K, Flanders KC, Sacks NP, Smith I, McKinna A, et al. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 1992;52:4261-4.
4. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-beta: biological function and chemical structure. Science 1986;233:532-4.
5. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985;313:745-7.
6. Jordan VC. Growth factor regulation by tamoxifen is demonstrated in patients with breast cancer [editorial] [see comment citation in Medline]. Cancer 1993;72:1-2.
7. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
8. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992;18:29-43.
9. Vanhee D, Gosset P, Wallaert B, Voisin C, Tonnel AB. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am J Respir Crit Care Med 1994; 150:1049-55.
10. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:197-204.
11. Deguchi Y, Kishimoto S. Spontaneous activation of transforming growth factor-beta gene transcription in broncho-alveolar mononuclear cells of individuals with systemic autoimmune diseases with lung involvement. Lupus 1991; 1:27-30.
12. Anscher MS, Crocker IR, Jirtle RL. Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res 1990;122:77-85.
13. Geraci JP, Mariano MS. Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury. Radiat Res 1993;136:205-13.
14. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993;134:63-70.
15. Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994;32:29-36.
16. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-9.
17. Finkelstein JN, Johnston CJ, Baggs R, Rubin P. Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 1994; 28:621-31.
18. Overgaard M, Bentzen SM, Christensen JJ, Madsen EH. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 1987;9:1-11.
19. Bentzen SM, Christensen JJ, Overgaard J, Overgaard M. Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy. Acta Oncol 1988;27:105-16.
20. Bentzen SM, Overgaard M. Early and late normal-tissue injury after postmastectomy radiotherapy. In: Hinkelbein W, Bruggmoser G, Frommhold H, Wannenmacher M, editors. Acute and long-term side-effects of radiotherapy. Berlin: Springer-Verlag, 1993:59-78.
21. Mouridsen HT, Rose C, Overgaard M, Dombernowsky P, Panduro J, Thorpe S, et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 1988;27:699-705.
22. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J, Nielsen OG, Madsen EH. Quantitative assessment of radiation-induced lung changes by computerized optical densitometry of routine chest x-rays. Int J Radiat Oncol Biol Phys 1996;34:421-7.
23. Thames HD Jr, Rozell ME, Tucker SL, Ang KK, Fisher DR, Travis EL. Direct analysis of quantal radiation response data. Int J Radiat Biol Relat Stud Phys Chem Med 1986;49:999-1009.
24. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma [see comment citations in Medline]. J Clin Oncol 1992;10:356-63.
25. Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, et al. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor positive early stage breast cancer. Int J Radiat Oncol Biol Phys 1995;32 Suppl 1:150.
26. Parry BR. Radiation recall induced by tamoxifen [letter]. Lancet 1992;340:49.
27. Bentzen SM, Overgaard M. Clinical radiobiology and normal-tissue morbidity after breast cancer treatment. In: Altman KI, Lett JT. editors. Advances in radiation biology. Vol. 18. San Diego: Academic Press, 1994:25-51.
28. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-8.
29. Anscher MS, Kong FM, Murase T, Jirtle RL. Short communication: normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TFG beta. Br J Radiol 1995;68:331-3.
30. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990;346:371-4.
31. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339:213-4.
32. Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice [see comment citation in Medline]. Thorax 1993;48:959-66.